Vivoryon Therapeutics N.V. ( OTC:VIVRF) Q2 2025 Earnings Call September 4, 2025 9:00 AM EDT ...

Satellos has the potential to produce substantial rewards if SAT-3247 can demonstrate sufficient muscle regeneration in DMD ...

Aug 28 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Thursday it has decided not to proceed with the development of its combination drug in patients with a type of arthritis, after ...

Southwest Research Institute scientists developed a new purification technique to improve chromatography results without expensive purification materials or equipment. Chromatography is an essential ...

API Business Division, New Materials Department, Osaka Plant, Towa Pharmaceutical Co., Ltd., 3-8 Matsuo-cho, Kadoma, Osaka 571-0044, Japan ...

The pharmaceutical industry faces pressure to improve the drug development process while reducing costs in an evolving regulatory landscape. This paper presents the Preclinical Information Center ...

An Indiana-based drug research company said a recent ransomware attack has disrupted its business operations and forced a shutdown of critical systems. Inotiv told regulators at the Securities ...

Heidelberg, Germany--(Newsfile Corp. - August 19, 2025) - BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new collaboration with ...

The small molecule, vatiquinone, had already flunked a Phase III trial, but the company pushed ahead with an approval bid anyway. The FDA has rejected PTC Therapeutics’ vatiquinone, the company’s ...

The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" training has been added to ResearchAndMarkets.com's offering.